Research Paper Volume 12, Issue 2 pp 1808—1827

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma

Figure 7. ISG20 improved the migration and invasion abilities of ccRCC cells in vitro. (AC) Transwell assays analysis of the effect of ISG20 knockdown on cell migration and invasion. (DF) Wound healing assays analysis of the effect of ISG20 knockdown on the migration of ccRCC cells. ccRCC: clear cell renal cell carcinoma. Data are represented as mean ± SD. ***, P < 0.001; **, P < 0.01; *, P < 0.05.